Latest News and Press Releases
Want to stay updated on the latest news?
-
For immediate release iSTAR Medical Presents Positive Consistent Results for MINIject® Across Three International Glaucoma Trials Analysis provides further validation of MINIject®’s meaningful and...
-
For immediate release iSTAR Medical Expands Commercial Rollout with First MINIject® Surgeries in Switzerland The only commercially available MIGS device currently targeting the supraciliary...
-
For immediate release iSTAR Medical Continues Market Expansion with First MINIject® Surgeries in the UK UK patients and surgeons now able to benefit from the only commercially available MIGS device...
-
For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the USPositive feedback from...
-
For immediate release iSTAR Medical shows initial positive progress of US STAR-V trial for MINIject Pivotal trial of MINIject, STAR-V, now initiated in 13 sites across the USPositive feedback from...
-
iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial...
-
Pour diffusion immédiate iSTAR Medical reçoit l’autorisation de mise sur le marché européen de l’implant pour glaucome MINIject Le seul dispositif supraciliaire micro-invasif disponible dans le...
-
Per distribuzione immediata iSTAR Medical ottiene l’approvazione alla commercializzazione in Europa del dispositivo medico per il glaucoma MINIject L’unico dispositivo sopracciliare mini-invasivo...
-
Voor onmiddellijke publicatie iSTAR Medical krijgt goedkeuring voor de Europese markt voor het glaucoomimplantaat MINIject Het enige commercieel verkrijgbare, minimaal invasieve supraciliaire...
-
iSTAR Medical receives European market approval for glaucoma implant MINIject The only commercially available, minimally invasive supraciliary device for glaucoma now approved First commercial...